Diagnostic imaging services provider Affidea has entered into a binding agreement to acquire Q Diagnostica from Atlanta Private Equity.
The move allows Affidea to foray into the Spanish market and expands its presence to 16 countries
Recently, Affidea entered into a binding agreement to acquire 23 centres in Romania. After it receives approval for the acquisition of Q Diagnostica, the company will have a total of 235 centres in Europe.
For the past 25 years, Q Diagnostica has been offering quality medical services for clients in the public and private sectors.
The company operates 35 MRI, 16 CT, 3 PET-CT scanners and many other diagnostics systems throughout its network of 34 modern medical centres located in 7 regions of Spain.
Affidea Group CEO Dimitris Moulavasilis said: "We are excited to add Q Diagnostica to our network and to expand into Spain; a country where healthcare is valued as a high priority.
“Our ambition is to become a country-wide operator with a solid value proposition for Spanish patients, the National Health System, private health insurers and the broader medical community.
“We have great respect for Q Diagnostica’s commitment to high quality operational excellence, and I believe it is a great platform in which to invest and to develop our position in the country further.”
Q Diagnostica CEO Inaki Equia Ventura said: "When we started Q Diagnostica more than 25 years ago, our ambition was to offer high-quality imaging services that are easily accessible for the Spanish people.
“Together with Affidea we will pursue this vital mission with added urgency. We are delighted to join a team of professionals who share our values and will help us take our business to the next level."
Affidea has network of medical centres across Europe. It specializes in diagnostic investigations, out-patient and cancer treatment services.